Abstract: The role of early defibrillation has been well established as a pivotal ring of the chain of survival since the nineties. In the following years, the scientific evidences about the beneficial role of early defibrillation have grown, and most of all, it has been demonstrated that the main determinant of survival is the time of defibrillation more than the type of rescuer. Early lay defibrillation was shown to be more effective than delayed defibrillation by healthcare providers. Moreover, because of the ease of use of automated external defibrillators (AEDs), it has been shown that also untrained lay rescuers can safely use an AED leading the guidelines to encourage early defibrillation by untrained lay bystanders. Although strong evidence has demonstrated that an increase in AED use leads to an increase in out-of-hospital cardiac arrest (OHCA) survival, the rate of defibrillation by laypeople is quite variable worldwide and very low in some realities. The review of this literature about lay defibrillation highlights that the AED is a life-saving device as simple and well tolerated as underused. #aed #publicaccessaed #defib #defibrillator #electrdoesfordefib #defibsaveslives #ocha #intelesens
Intelesens Ltd
Medical Equipment Manufacturing
Belfast, Antrim 770 followers
We are a specialist manufacturer of defibrillator and ECG electrodes offering a complete end-to-end service.
About us
Intelesens, founded in 2000, is a specialist manufacturer of defibrillator and ECG electrodes based in Belfast, Northern Ireland. We have created a flexible partnership approach to developing, validating and manufacturing bespoke defibrillation and ECG electrodes, tailored to meet our client's exacting requirements. We work with a wide range of international clients, from start up companies developing initial concept designs to contract production for well-established multi-national providers. We have the experience, knowledge, and in-house facilities to deliver a cost-effective solution that’s right for your business.
- Website
-
http://www.intelesens.com
External link for Intelesens Ltd
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Belfast, Antrim
- Type
- Privately Held
- Founded
- 2000
- Specialties
- Biomedical Engineering, Defibrillator Electrode Manufacturing, Medical Device Design, ECG electrode manufacture, concept development, Human Factor Evaluation, Regulatory Compliance, Design and Prototyping, Optimised material supply, and contract Manufacture
Locations
-
Primary
17 Heron Road
Belfast, Antrim BT3 9LE, GB
Employees at Intelesens Ltd
Updates
-
https://lnkd.in/eqAqyg2z Introduction: Cardiac arrest results in a high death rate if cardiopulmonary resuscitation and early defibrillation are not performed. Mortality is strongly linked to regulations, in terms of prevention and emergency-urgency system organization. In Italy, training of lay rescuers and the presence of defibrillators were recently made mandatory in schools. This study aimed to analyse Out-of-Hospital Cardiac Arrest (OHCA) events in pediatric patients (under 18 years old), to understand the epidemiology of this phenomenon and provide helpful evidence for policy-making. Methods: A retrospective observational analysis was conducted on the emergency databases of Lombardy Region, considering all pediatric OHCAs managed between 1 January 2016, and 31 December 2019. The demographics of the patients and the logistics of the events were statistically analyzed. Results: The incidence in paediatric subjects was 4.5 (95% CI 3.6-5.6) per 100,000 of the population. School buildings and sports facilities had relatively few events (1.9% and 4.4%, respectively), while 39.4% of OHCAs were preventable, being due to violent accidents or trauma, mainly occurring on the streets (23.2%). Conclusions: Limiting violent events is necessary to reduce OHCA mortality in children. Raising awareness and giving practical training to citizens is a priority in general but specifically in schools. #ohca #aedtraining #defibrillator #betterpatientoutcomes #intelesens
Out-of-Hospital Cardiac Arrest in the Paediatric Patient: An Observational Study in the Context of National Regulations - Intelesens
https://intelesens.com
-
Intelesens Ltd reposted this
Northern Ireland boasts over 250 companies specialising in life and health sciences, leading the way in medical devices, diagnostics, AI, and precision medicine. We had 4 successful days in Dubai at the Arab Health Exhibition, where we showcased 6 leading companies specialising in providing innovative solutions. Listen to our partners Armstrong Medical Ltd, Biopanda Reagents, CIGA Healthcare Ltd, Cirdan Ltd, Intelesens Ltd, and Neurovalens talk about the benefits of attending #ArabHealth for their global outreach. Thank you to all who visited our stand. If you missed us, please connect with our team members, Sheethal Rishi, Fahd Asif, and Urginia Mhlaba, to learn more about how Northern Ireland transforms lives through cutting-edge medical devices, products, and healthcare solutions. #NorthernIreland #InvestNI #LifeandHealth #ArabHealth #ArabHealth2024 #FutureofHealthcare #Trade #Dubai #UAE Invest Northern Ireland I Sergio De la Puente l Cheryl Wallace I Roy Neill I Philip McKee I Irwin Armstrong I Philip Moore I Stephen Henderson I Jason McKeown
-
A defibrillator should be connected to all patients receiving cardiopulmonary resuscitation (CPR) to allow early defibrillation. The defibrillator will collect signal data such as the electrocardiogram (ECG), thoracic impedance and end-tidal CO2, which allows for research on how patients demonstrate different responses to CPR. The aim of this review was to give an overview of methodological challenges and opportunities in using defibrillator data for research. #cpr #defibrillation #ai #artificialintelligence #electrodesfordefib #medicalelectrodes #intelesens Link to full article; https://lnkd.in/grawPAer
Extracting physiologic and clinical data from defibrillators for research purposes to improve treatment for patients in cardiac arrest - Intelesens
https://intelesens.com
-
Out-of-hospital cardiac arrest is a global public health issue experienced by approximately 3.8 million people annually. Only 8% to 12% survive to hospital discharge. Early defibrillation of shockable rhythms is associated with improved survival, but ensuring timely access to defibrillators has been a significant challenge. To date, the development of public-access defibrillation programs, involving the deployment of automated external defibrillators into the public space, has been the main strategy to address this challenge. Public-access defibrillator programs have been associated with improved outcomes for out-of-hospital cardiac arrest; however, the devices are used in <3% of episodes of out-of-hospital cardiac arrest. This scientific statement was commissioned by the International Liaison Committee on Resuscitation with 3 objectives: 1. Identify known barriers to public-access defibrillator use and early defibrillation 2. Discuss established and novel strategies to address those barriers, and 3. Identify high-priority knowledge gaps for future research to address. The writing group undertook systematic searches of the literature to inform this statement. Innovative strategies were identified that relate to enhanced public outreach, behaviour change approaches, optimisation of static public-access defibrillator deployment and housing, evolved automated external defibrillator technology and functionality, improved integration of public-access defibrillation with existing emergency dispatch protocols, and exploration of novel automated external defibrillator delivery vectors. The study provides evidence- and consensus based policy suggestions to enhance public-access defibrillation and guidance for future research in this area. Full article information below; https://lnkd.in/grfZ6XGc #publicaccessaed #aed #defibrillation #OHCA #optimisingsurvival #electrodesfordefib #5yrshelflife #intelesens
Optimising outcomes after out-of-hospital cardiac arrest with innovative approaches to public-access defibrillation: A scientific statement from the International Liaison Committee on Resuscitation - Intelesens
https://intelesens.com
-
Intervention by members of the public during an out of hospital cardiac arrest (OHAC) including resuscitation attempts and accessible automated external defibrillator (AED) has been shown to improve survival. This study aimed to investigate the OHCA and AED knowledge and confidence, and barriers to intervention, of the public of North East England, UK. This study used a face-to-face cross-sectional survey on a public high street in Newcastle, UK. Participants were asked unprompted to explain what they would do when faced with an OHCA collapse. Of the 421 participants recruited in the study, 82.9% (n = 349) reported that they would know what to do during an OHCA collapse. The most frequent OHCA action mentioned was call 999 at 64.1% and 58.2% of participants reported that they would commence CPR. However, only 14.3% of participants spontaneously mentioned that they would locate an AED, while only 4.5% recounted that they would apply the AED. Just over half of participants were first aid trained, with statistically more females than males being first aiders. Most participants knew what an AED was, and 34.7% reported that they knew how to use one, however, only 11.9% mentioned that they would actually shock a patient. Being first aid trained increased the likelihood of freely recounting actions for OHCA and AED intervention. The most common barrier to helping during an OHCA was lack of knowledge. Although most participants reported they would know what to do during an OHCA and had knowledge of an AED, low numbers of participants spontaneously mentioned specific OHCA and AED actions. Improving public knowledge would help improve the public’s confidence of intervening during an OHCA and may improve OHCA survival. Full article; https://lnkd.in/eWWw3jPR #ohca #bystander #cpr #firstaid #defibrillator #defib #aed #electrodesfordefib #intelesens
Knowledge and barriers of out of hospital cardiac arrest bystander intervention and public access automated external defibrillator use in the Northeast of England: a cross-sectional survey study - Intelesens
https://intelesens.com
-
A big thank you to all who visited us at Arab Health Exhibition 2024. This year proved to be another success for both meeting current industry partners and cultivating new partnerships. Thank you also to Invest Northern Ireland for having us on their stand. #arabhealth2024 #medicalelectrodes #electrodesfordefib #completeelectrodepartner #intelesens
-
-
Day 1 is well under way at Arab Health Exhibition 2024! The team are ready to answer any queries you may have regarding medical electrodes and sensors, so be sure to stop by to Stand H2.G30 to speak to the Intelesens team! #arabhealth #arabhealth24 #medicalelectrodes #medicalsensors #medtech #innovation #intelesens
-
-
Intelesens Ltd reposted this
Northern Ireland has established itself as a hub for cutting-edge healthcare solutions solving global healthcare challenges, owing to talented individuals, advanced research facilities, and strong partnerships between industry, academia, and medical professionals. If you're interested in learning more about Northern Ireland's impressive track record of health innovation, we invite you to visit our stand no. G30 at the Arab Health Exhibition. You'll have the opportunity to meet Northern Ireland's leading companies in the field, such as Armstrong Medical Ltd, Biopanda Reagents, CIGA Healthcare Ltd, Cirdan Ltd, Intelesens Ltd, and Neurovalens, and connect with our team Sheethal Rishi, Fahd Asif, and Urginia Mhlaba. #NorthernIreland #InvestNI #LifeandHealth #ArabHealth #ArabHealth2024 #FutureofHealthcare #Trade #Dubai #UAE
-
-
Tomorrow is kick off at Arab Health Exhibition 2024! The Intelesens team are looking forward to meeting you at the Invest Northern Ireland stand H2.G30 to discuss any medical electrode inquiry you may have whether it is for design, development or manufacture. We look forward to seeing you! #arabhealth24 #medicalelectrode #sensors #innovation #medtech #intelesens
-